KRAJICKOVA, Dagmar, Jiří KRÁL, Roman HERZIG, L'udovit KLZO, Antonin KRAJINA, Jaroslav HAVELKA, Libor SIMUNEK, Oldrich VYSATA, Tran Van QUANG, Michal BAR and Martin VALIS. Factors influencing therapy choice and clinical outcome in cerebral venous sinus thrombosis. Scientific Reports. USA: NATURE RESEARCH, 2020, vol. 10, No 1, p. 1-8. ISSN 2045-2322. Available from: https://dx.doi.org/10.1038/s41598-020-78434-8.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Factors influencing therapy choice and clinical outcome in cerebral venous sinus thrombosis
Authors KRAJICKOVA, Dagmar (203 Czech Republic), Jiří KRÁL (203 Czech Republic, belonging to the institution), Roman HERZIG (203 Czech Republic), L'udovit KLZO (203 Czech Republic), Antonin KRAJINA (203 Czech Republic), Jaroslav HAVELKA (203 Czech Republic), Libor SIMUNEK (203 Czech Republic), Oldrich VYSATA (203 Czech Republic), Tran Van QUANG (203 Czech Republic), Michal BAR (203 Czech Republic) and Martin VALIS (203 Czech Republic, guarantor).
Edition Scientific Reports, USA, NATURE RESEARCH, 2020, 2045-2322.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30103 Neurosciences
Country of publisher Germany
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 4.379
RIV identification code RIV/00216224:14110/20:00118096
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1038/s41598-020-78434-8
UT WoS 000609190200007
Keywords in English cerebral venous sinus thrombosis
Tags 14110127, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 2/2/2021 10:36.
Abstract
We aimed was to assess the factors influencing therapy choice and clinical outcome after 3-4 months in patients with cerebral venous sinus thrombosis (CVST). In a retrospective, bi-centric study, the set consisted of 82 consecutive CVST patients (61 females; mean age 33.5 +/- 15.7 years). Following data were collected: baseline characteristics, presence of gender-specific risk factors (GSRF), location and extent of venous sinus impairment, clinical presentation, type of treatment, recanalization, presence of parenchymal lesions, and clinical outcome after 3-4 months (assessed using the modified Rankin Scale [mRS], with excellent outcome defined as mRS 0-1). Multivariate logistic regression analysis was used for statistical evaluation. After 3-4 months, complete recovery was achieved in 41 (50%) and excellent clinical outcome in 67 (81.7%) patients. Female sex (OR 0.11; p=0.0189) and presence of focal neurologic deficit (OR 0.16; p=0.0165) were identified as significant independent negative predictors and, the presence of GSRF (OR 15.63; p=0.0011) as significant independent positive predictor of excellent clinical outcome. In conclusion, in our CVST patients, the presence of GSRF was associated with excellent clinical outcome, while the female sex itself was associated with poorer clinical outcome.
PrintDisplayed: 23/7/2024 22:11